CROUSE HOSPITAL — History
CCN 330203 | 3-year financial timeline | COVID resilience: 74/100
🛡️ Public data only — no PHI permitted on this instance.
$506M
Latest Revenue (FY2022)
+13.4%
Revenue CAGR (3yr)
-0.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $393M | $436M | $506M | +16.1% | +13.4% |
| Operating Expenses | $415M | $467M | $509M | +9.2% | +10.8% |
| Operating Margin | -5.5% | -7.1% | -0.7% | +90.4% | +0.0% |
| Net Income | $-22M | $-31M | $-3M | +88.9% | +0.0% |
| Licensed Beds | 502 | 502 | 502 | +0.0% | +0.0% |
| Total Patient Days | 109,277 | 123,526 | 123,670 | +0.1% | +6.4% |
| Medicare Day % | 21% | 21% | 20% | -3.8% | -2.0% |
| Medicaid Day % | 7% | 6% | 5% | -6.4% | -14.1% |
COVID Impact & Recovery
Resilience Score: 74/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +28.6% ($393M → $506M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+13.4%
This Hospital
+7.6%
State Avg
Latest Margin
-0.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $562M | 1.7% |
| FY2024 (proj) | $618M | 4.2% |
| FY2025 (proj) | $675M | 6.6% |